Search by Drug Name or NDC

    NDC 10019-0653-64 SEVOFLURANE 250 mL/250mL Details

    SEVOFLURANE 250 mL/250mL

    SEVOFLURANE is a RESPIRATORY (INHALATION) LIQUID in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is SEVOFLURANE.

    Product Information

    NDC 10019-0653
    Product ID 10019-653_8faf6015-7ba0-4f71-a0ed-9148f7be0a70
    Associated GPIs 70200070002000
    GCN Sequence Number 023743
    GCN Sequence Number Description sevoflurane LIQUID INHALATION
    HIC3 H2B
    HIC3 Description GENERAL ANESTHETICS,INHALANT
    GCN 12640
    HICL Sequence Number 010027
    HICL Sequence Number Description SEVOFLURANE
    Brand/Generic Generic
    Proprietary Name SEVOFLURANE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Sevoflurane
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LIQUID
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 250
    Active Ingredient Units mL/250mL
    Substance Name SEVOFLURANE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class General Anesthesia [PE], General Anesthetic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075895
    Listing Certified Through 2024-12-31

    Package

    NDC 10019-0653-64 (10019065364)

    NDC Package Code 10019-653-64
    Billing NDC 10019065364
    Package 6 BOTTLE in 1 CARTON (10019-653-64) / 250 mL in 1 BOTTLE
    Marketing Start Date 2002-07-07
    NDC Exclude Flag N
    Pricing Information N/A